Valerie Morisset

Insider Reports History

Entity
Individual
Location
C/O Eliem Therapeutics, Inc., 23515 Ne Novelty Hill Rd, Ste B221 #125, Redmond, WA
Signature
/s/ Alan Hambelton, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Valerie Morisset:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eliem Therapeutics, Inc. EVP, R&D AND CSO Common Stock 31.3K $250K $7.98 Jul 22, 2024 Direct
Eliem Therapeutics, Inc. EVP, R&D AND CSO Stock Option (Right to Buy) 10.2K Jul 1, 2024 Direct

Insider Reports Filed by Valerie Morisset

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELYM Eliem Therapeutics, Inc. Jul 19, 2024 4 -$988K 4 Jul 23, 2024 EVP, R&D AND CSO
ELYM Eliem Therapeutics, Inc. Jul 17, 2024 2 -$289K 4 Jul 19, 2024 EVP, R&D AND CSO
ELYM Eliem Therapeutics, Inc. Jul 16, 2024 1 -$357K 4 Jul 17, 2024 EVP, R&D AND CSO
ELYM Eliem Therapeutics, Inc. Jul 12, 2024 2 -$651K 4 Jul 16, 2024 EVP, R&D AND CSO
ELYM Eliem Therapeutics, Inc. Jul 9, 2024 3 -$737K 4 Jul 11, 2024 EVP, R&D AND CSO
ELYM Eliem Therapeutics, Inc. Jul 5, 2024 1 -$87.1K 4 Jul 9, 2024 EVP, R&D AND CSO
ELYM Eliem Therapeutics, Inc. Jul 1, 2024 3 -$338K 4 Jul 3, 2024 EVP, R&D AND CSO
ELYM Eliem Therapeutics, Inc. Apr 5, 2024 2 $3.57 4 Apr 8, 2024 EVP, R&D AND CSO
ELYM Eliem Therapeutics, Inc. Sep 20, 2023 4 $13.90 4 Mar 4, 2024 EVP, R&D AND CSO
ELYM Eliem Therapeutics, Inc. Mar 10, 2023 4 $523 4 Mar 14, 2023 EVP, R&D and CSO
ELYM Eliem Therapeutics, Inc. Oct 31, 2022 1 $0 4 Nov 2, 2022 EVP, R&D and CSO
ELYM Eliem Therapeutics, Inc. Jan 27, 2022 1 $0 4 Jan 31, 2022 EVP, R&D and CSO
ELYM Eliem Therapeutics, Inc. Aug 9, 2021 0 $0 3 Aug 9, 2021 Chief Scientific Officer